Detail Information
Publications
Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancerA D Thor
Department of Pathology, Evanston Hospital Northwestern University, Evanston, IL 60201, USA
J Clin Oncol 18:3230-9. 2000..This study was designed to compare the incidence and prognostic value of ErbB-2 (HER-2/neu) and P-ErbB-2 immunoexpression in archival breast cancer samples...
HER2--a discussion of testing approaches in the USAA Thor
Department of Pathology, Northwestern University Medical School, Chicago, Illinois, USA
Ann Oncol 12:S101-7. 2001..Data from the Cancer and Leukemia Group B trial 8541 (companion 8869) suggest that, with proper controls in high-volume laboratories, many of the available methods produce comparable results...
